Best Denton County Grants for Nonprofits in Texas

American Gastroenterological Association

The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, AGA represents members from around the globe who are involved in all aspects of the science, practice, and advancement of gastroenterology. The AGA Institute administers the practice, research, and educational programs of the organization.

AGA-Takeda Pharmaceuticals Research Scholar Award in Inflammatory Bowel Disease

This award provides funding for three years to early-career faculty (i.e., investigator, instructor, research associate or equivalent) working toward an independent career in inflammatory bowel disease (IBD) research.

Objective

The objective of the AGA Research Foundation Research Scholar Award (RSA) is to support early-career investigators working toward independent and productive research careers in digestive diseases by ensuring that a major proportion of their time is protected for mentored research (i.e., a minimum of 50 percent effort dedicated to the proposed project). This award will support junior faculty (not fellows) who have demonstrated exceptional promise and have some record of accomplishment in research pertaining to inflammatory bowel disease.

Review all of the benefits AGA Research Scholar Award recipients are entitled to on the award policies page.

Application Requirements

• Maintain AGA membership throughout the three-year duration of the award.

• Applicants must self-assign their proposal to one of the following categories:
  • Clinical: Research involving direct contact with human subjects or using clinical data to address problems related to the prevention, diagnosis, treatment or outcome of human diseases (e.g., clinical epidemiology). This category also includes research related to health care delivery (e.g., health services, health IT).
  • Basic/Translational: Research with a primary goal of understanding basic biology or disease mechanisms. This category can involve animal subjects, cell culture, human biospecimens or human data as resources for laboratory- or informatics-based investigation.

• Resources allocated through this award are intended to support the career development of the applicant. The applicant must allocate a minimum of 50 percent effort to the proposed project.

• Applicants are required to have a sponsor and mentor for the award; one individual may serve in the capacity of both positions. A sponsor (typically a division chief or department chair) is an individual who takes responsibility for the quality assessment of the proposed research project, the quality of the research environment within which the project will be undertaken, and the experience and expertise of the principal investigator and other key researchers involved. A mentor will supervise the principal investigator’s research activities ensuring timelines and deliverables and will work with the applicant to create a research career development plan.

• The intent of this award is to foster the scientific independence of junior investigators. Applicants whose research activities become incorporated into a grant application from a senior mentor will need to delineate clearly the scientific and experimental distinctions between their respective programs. This requirement applies both to pending applications submitted prior to review of this award and to applications submitted during the term of the RSA. It must also be clearly stated how the work submitted by the applicant is that of the applicant and not that of the senior mentor(s).

• A complete research facilities and resources form must be submitted.

• Biographical sketches for the applicant, mentor and other key personnel must be submitted.

• Applicants resubmitting a revised application from a prior cycle must include a resubmission report describing responses to reviewer feedback and other major changes since the most recent past submission.

• Upon notification of receipt of this award, the recipient must provide institutional approval from the appropriate committee(s) for use of human subjects or animals. If approval is not necessary, then the recipient must provide documentation from the appropriate regulatory committee.

• Recipients must submit scientific and financial progress reports to AGA annually and final reports 60 days after the end date of the award period. Report templates and instructions are provided to awardees at the time of acceptance. Second and third year funding are contingent upon the submission and accuracy of this documentation.

• All publications, presentations, abstracts, and patent applications arising from work funded by this program must acknowledge support of the AGA–Takeda Pharmaceuticals Research Scholar Award in Inflammatory Bowel Disease.

• Additional pre-award policies are available on the Research Award Policies page.

Award Overlap

• At the time of application submission, applicants may not hold, or have held, an NIH K01, K08, K23, K99, R00, R01, R21, R29, Veterans Affairs Career Development Award or any award with similar objectives from non-federal sources (e.g., the American Liver Foundation, Crohn’s and Colitis Foundation of America, Robert Wood Johnson Foundation).

• Applicants who have held a K12 or KL2 in the past are eligible to apply. Applicants with an active K12 or KL2 may apply in the final year of their active K12 or KL2 so long as the award will end before the Research Scholar Award term begins.

• If a applicant is granted the award and notified of a comparable award from another agency prior to the first payment of this award, then the recipient must select one of the two awards (i.e., the recipient may not retain both awards).

• If the recipient is notified that a comparable award has been granted after the first payment of this award, then the recipient may retain up to 50 percent of the remainder of his or her AGA award. AGA must be notified by the recipient via email within two weeks of receiving notification of additional funding.